Co-founder of Cambridge Molecular, a computational drug discovery company working on new ways of discovering medicines. Cambridge Molecular creates tools that leverage novel machine learning algorithms and large-scale cloud computing to discover better medicines.TMT Investments plc is a publicly traded venture capital firm investing in high-growth technology companies, with over sixty-five early investments made to date - three of which have grown into unicorns. Feel free to reach out if you have achieved product-market fit and are seeking VC funding.
-
Chief Operating OfficerCambridge MolecularCambridge, Gb -
Chief Operating OfficerCambridge Molecular Jan 2023 - PresentCambridge, England, United KingdomCambridge Molecular is a computational drug discovery company devoted to DNA-encoded libraries and other next-generation small molecule screening technologies. We leverage novel algorithms and high-performance cloud computing to accelerate and derisk drug discovery. -
Chief Executive OfficerCambridge Molecular Mar 2019 - Jan 2023Cambridge, United Kingdom -
AdviserTmt Investments Plc Aug 2020 - PresentLondon, England, United Kingdom -
Director Of StrategySyntheticgestalt May 2018 - Mar 2019Cambridge, United Kingdom
Dmitry Foxham Education Details
-
Distinction -
First-Class Honours
Frequently Asked Questions about Dmitry Foxham
What company does Dmitry Foxham work for?
Dmitry Foxham works for Cambridge Molecular
What is Dmitry Foxham's role at the current company?
Dmitry Foxham's current role is Chief Operating Officer.
What schools did Dmitry Foxham attend?
Dmitry Foxham attended University Of Cambridge, University Of Cambridge, Harrow School.
Free Chrome Extension
Find emails, phones & company data instantly
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial